← back to search

Roger K. Sunahara

University of California San Diego · US
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Neuropeptides and Animal Physiology, and Protein Kinase Regulation and GTPase Signaling.
h-index
63
citations
25,888
works
196
NIH funding
primary concept
email

Recent publications

Structure and dynamics determine G protein coupling specificity at a class A GPCR
Science Advances 2025cited by 33position: middledoi
Mapping the conformational landscape of the stimulatory heterotrimeric G protein
Nature Structural & Molecular Biology 2023cited by 29position: middledoi
Non-canonical β-adrenergic activation of ERK at endosomes
Nature 2022cited by 112position: middledoi
Delineating the conformational landscape of the adenosine A2A receptor during G protein coupling
Cell 2021cited by 156position: middledoi
A photoswitchable GPCR-based opsin for presynaptic inhibition
Neuron 2021cited by 99position: middledoi
Integrative RNA-omics Discovers <i>GNAS</i> Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms
Cancer Discovery 2021cited by 54position: middledoi
Leveraging nonstructural data to predict structures and affinities of protein–ligand complexes
Proceedings of the National Academy of Sciences 2021cited by 38position: middledoi
Structure of a D2 dopamine receptor–G-protein complex in a lipid membrane
Nature 2020cited by 217position: middledoi
Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR
Cell Research 2020cited by 134position: middledoi
An allosteric modulator binds to a conformational hub in the β2 adrenergic receptor
Nature Chemical Biology 2020cited by 80position: middledoi
Structure and selectivity engineering of the M <sub>1</sub> muscarinic receptor toxin complex
Science 2020cited by 59position: middledoi
Structure of an endosomal signaling GPCR–G protein–β-arrestin megacomplex
Nature Structural & Molecular Biology 2019cited by 226position: middledoi
Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist
Nature Chemical Biology 2018cited by 201position: middledoi
Mechanistic insights into allosteric regulation of the A2A adenosine G protein-coupled receptor by physiological cations
Nature Communications 2018cited by 158position: middledoi
Rules of Engagement: GPCRs and G Proteins
ACS Pharmacology & Translational Science 2018cited by 131position: middledoi
Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
Proceedings of the National Academy of Sciences 2018cited by 95position: middledoi
Structure-based discovery of selective positive allosteric modulators of antagonists for the M <sub>2</sub> muscarinic acetylcholine receptor
Proceedings of the National Academy of Sciences 2018cited by 72position: lastdoi
Genetic evidence that β-arrestins are dispensable for the initiation of β <sub>2</sub> -adrenergic receptor signaling to ERK
Science Signaling 2017cited by 207position: middledoi
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
Cell 2016cited by 565position: middledoi
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs
Nature 2016cited by 295position: lastdoi
Mechanistic insights into GPCR–G protein interactions
Current Opinion in Structural Biology 2016cited by 134position: lastdoi
Structural basis for nucleotide exchange in heterotrimeric G proteins
Science 2015cited by 310position: middledoi
Conformational biosensors reveal GPCR signalling from endosomes
Nature 2013cited by 839position: middledoi
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Nature 2012cited by 1,351position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian K. Kobilka · Stanford University10 papers (2012–2025)Jacob P. Mahoney · University of Minnesota System6 papers (2013–2019)Peter Gmeiner · Friedrich-Alexander-Universität Erlangen-Nürnberg4 papers (2018–2025)Harald Hübner · Friedrich-Alexander-Universität Erlangen-Nürnberg4 papers (2018–2025)Jan Steyaert · Vrije Universiteit Brussel4 papers (2013–2019)Brian K. Shoichet · Quantitative BioSciences3 papers (2018–2020)Jonas Kaindl · Friedrich-Alexander-Universität Erlangen-Nürnberg3 papers (2018–2020) · 3 papers (2018–2020)Adnan Sljoka · York University3 papers (2018–2023)R. Scott Prosser · University of Toronto3 papers (2018–2023)Nicolas Villanueva · Cancer Center of Hawaii3 papers (2015–2021)Aashish Manglik · Chan Zuckerberg Initiative (United States)3 papers (2012–2016)Ron O. Dror · Stanford University3 papers (2015–2021)Asuka Inoue · Thomas Jefferson University3 papers (2017–2025)Robert J. Lefkowitz · Howard Hughes Medical Institute3 papers (2016–2025)Matthieu Masureel · Gene Therapy Laboratory2 papers (2016–2018)Oliver P. Ernst · University of Toronto2 papers (2018–2023)Arthur Christopoulos · ARC Centre of Excellence for Innovations in Peptide and Protein Science2 papers (2018–2018)A. Thomsen · New York University2 papers (2016–2019) · 2 papers (2017–2020)